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Abstract
Introduction
Acute kidney injury is associated with a poor prognosis in acute liver failure but little is
known of outcomes in patients undergoing transplantation for acute liver failure who require
renal replacement therapy.
Methods
A retrospective analysis of the United Kingdom Transplant Registry was performed (1 Janu-
ary 2001–31 December 2011) with patient and graft survival determined using Kaplan-
Meier methods. Cox proportional hazards models were used together with propensity-score
based full matching on renal replacement therapy use.
Results
Three-year patient and graft survival for patients receiving renal replacement therapy were
77.7% and 72.6% compared with 85.1% and 79.4% for those not requiring renal replace-
ment therapy (P<0.001 and P = 0.009 respectively, n = 725). In a Cox proportional hazards
model, renal replacement therapy was a predictor of both patient death (hazard ratio (HR)
1.59, 95% CI 1.01–2.50, P = 0.044) but not graft loss (HR 1.39, 95% CI 0.92–2.10, P =
0.114). In groups fully matched on baseline covariates, those not receiving renal replace-
ment therapy with a serum creatinine greater than 175μmol/L had a significantly worse risk
of graft failure than those receiving renal replacement therapy.
Conclusion
In patients being transplanted for acute liver failure, use of renal replacement therapy is a
strong predictor of patient death and graft loss. Those not receiving renal replacement
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Data Availability Statement: The study in itself does
not involve the use of donated tissue and/or organs.
This is a registry study of anonymised donors and
recipients from data routinely collected by NHSBT.
The donors and/or donor families have consented/
assented to the use of tissues for transplantation and
recipients have undergone a formal consent process
prior to transplantation. The study data is available on
request from National Health Service Blood and
Transplant (NHSBT). NHSBTcollects, records and
analyses data concerning potential and actual organ
therapy with an elevated serum creatinine may be at greater risk of early graft failure than
those receiving renal replacement therapy. A low threshold for instituting renal replacement
therapy may therefore be beneficial.
Introduction
The management of acute liver failure (ALF) has been transformed by the introduction of liver
transplantation. ALF is associated with significant morbidity and mortality, with outcome
dependent on several factors [1]. The King’s College Hospital Criteria2 were developed to pre-
dict survival and identify individuals requiring transplantation in whom spontaneous recovery
is unlikely. Elevated serum creatinine, a marker of renal impairment, is known to be a predictor
of poorer patient survival and is included as a factor for acetaminophen-induced ALF in the
King’s college criteria [2].
Furthermore, renal impairment is associated with reduced survival in patients undergoing
both elective and urgent orthotopic liver transplants [3]. Estimates suggest around 20% of
patients with chronic liver failure develop renal dysfunction [4]. In acute liver failure renal dys-
function occurs in up to two-thirds of patients [5], with up to half requiring renal replacement
therapy before transplantation [6].
Elevated pre-operative serum creatinine levels are associated with increased risk of post-
operative sepsis [7–9], the requirement for post-operative dialysis [9, 10] and short-term graft
and patient survival [3, 11] in orthotopic liver transplantation.
However, the relationship between renal impairment, renal replacement therapy (RRT) and
patient and graft survival following liver transplantation in ALF remains unclear. A single-cen-
tre study suggested pre-operative renal dysfunction significantly reduces patient survival [5]
but it is not known if reduction in elevated serum creatinine through RRT increases long-term
patient and graft survival post-operatively.
Using a national database covering a 10-year period, we aimed to perform a population-
based cohort study comparing patients undergoing liver transplantation for acute liver failure
with and without a requirement for RRT. To minimise confounding factors as far as is possible,
we used propensity-score based matching to balance treatment groups.
Materials and Methods
Data were extracted from the United Kingdom Transplant Registry (UKTR), a mandatory reg-
istry held by National Health Service (NHS) Blood and Transplant on 16th August 2012 for the
period 1 January 2001 and 31 December 2011. Permission was provided by NHS Blood and
Transplant to explore outcomes following donation after cardiac (DCD) and brain death
(DBD) liver transplantation. This study used only anonymised data obtained as part of usual
care and thus did not need NHS ethical review under the terms of the Governance Arrange-
ments for Research Ethics Committees (A Harmonised Edition) [12]. All data was anonymised
by NHS Blood and Transplant.
Data included all first-time deceased donor liver-only transplant patients receiving liver
transplantation for ALF (United Kingdom (UK) Transplant Super Urgent Scheme Category
1–10; S1 Table). In the UK, patients with ALF who are predicted by the King’s college criteria
[2] as unlikely to spontaneously recover liver function and meet psychological and other crite-
ria are eligible for transplantation, receiving national priority for any donor that becomes avail-
able. Patients do not have chronic liver disease, except in the circumstance of re-
transplantation for hepatic artery thrombosis which was excluded in this analysis. Graft sur-
vival was defined as all-cause graft loss including graft failure or patient death, whichever came
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first. In addition, data did not include patients less than 18 years old, split or reduced liver
transplants, multi-organ transplants or heterotopic transplants.
Data were collected for pre-operative recipient characteristics immediately prior to trans-
plantation: age, gender, race, serum creatinine, urea, bilirubin, albumin, sodium, potassium,
haemoglobin, white blood cell count, platelet count, aetiology of liver failure, encephalopathy
grade, intracranial pressure monitoring status, presence of sepsis, life-style activity score (S2
Table), ventilatory support status and the use of renal replacement therapy (both haemodialysis
and filtration). Within the UK indication for commencing RRT is centre-specific, however
national guidelines suggest its use in the presence of refractory hyperkalaemia/electrolyte
abnormalities, acute kidney injury with severe organ failure, refractory pulmonary oedema and
oliguria (<0.3 ml/kg/hr for 24 hours) [13]. Liver failure aetiology was determined according to
the classification system described by Gotthardt et al for acute liver failure [14]: viral, drug tox-
icity, metabolic, vascular, and miscellaneous aetiology.
Data were collected for donor characteristics: age, gender, weight, height, race, cause of
death, donor type (DCD/DBD), presence of steatosis, and cold ischaemic time; together with
operative characteristics: organ anatomy, operative reperfusion time and number of blood
units used intra-operatively.
Kaplan-Meier survival methods with a log-rank test were used to identify pre-operative fac-
tors which influenced graft and patient survival. Hazard ratios and confidence intervals (CI)
were determined for patient and graft survival using Cox proportional hazards model (CPH).
In univariable analyses, continuous variables were dichotomized according to mean values,
while in multivariable models these were treated as continuous: for example, age (<40 vs.40
years), creatinine (<120 vs.120 μmol/L), urea (<5 vs.5 μmol/L) and haemoglobin (<10
vs.10 g/dL). A CPH model was used to determine independent risk factors predicting sur-
vival following transplantation for ALF using variables found to be significant in univariable
analysis. When performing the analysis, creatinine was centred at 90 μmol/L for RRT in order
to provide interpretation at a clinically relevant creatinine concentration The underlying haz-
ard function was assessed and seen to be constant, and no time dependent variables were speci-
fied. Calibration of the final CPH model with actual patient survival was checked and found to
be reasonable (S1 Fig). We explored applying a cubic spline to the continuous variables in
order to enhance calibration, however this did not significantly improve model fit.
The measures above go some way to controlling for differences in characteristics between
treatment groups. However, it is acknowledged that significant selection bias exists in assigning
patients to one treatment or the other [15]. In order to try and reduce the influence of selection
bias as far as is possible, propensity-score matching was performed using all available recipient
variables: gender, age, ethnicity, cause of liver failure, life-style activity score, ventilation status,
encephalopathy grade, intracranial pressure monitoring status, sepsis status, haemoglobin,
white cell count, platelet count, albumin, bilirubin and sodium. Logistic regression was used to
determine the probability of treatment group membership, which was used for matching.
“Nearest neighbour” matching is often utilised, however, with these data there is an excess of
patients in the treated group compared to the control. Covariate balance is not possible using
this method. “Full matching” is used in which a fully matched sample is composed of matched
sets, where each matched set contains one treated unit and one or more controls (or one con-
trol unit and one or more treated units) [16].
Full matching is optimal in minimizing a weighted average of the estimated distance mea-
sure between each treated subject and each control subject within each subclass. This can be
thought of as “weighting” the control group to look as similar to the treated group as possible.
Thus, as an example, to optimally match a single patient in the treated group, it may be best to
use two patients from the control group with each given a weighting of 0.5. The distribution of
RRT and Survival in Liver Transplantation
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the propensity scores in treated and control groups was checked (S2 Fig) and covariate balance
determined (S3 Table). Cox proportional hazards models were constructed using the matched
dataset and used to identify factors predicting patient and graft survival, including graphical
representations. The matching and weighting are accounted for in the analysis by specifying
the subclass as a cluster, thus ensuring robust estimation of the variance, and adjusting the con-
tribution of each patient to the analysis using the weight determined above [17].
All statistical analysis was performed using R 2.15.3 (R Foundation for Statistical Comput-
ing) with Zelig [18], survival, epitools, rms, Match-It and optmatch packages. Statistical signifi-
cance is two-sided and data are presented as mean with bootstrapped 95% CI, unless stated
otherwise.
Results
Patient characteristics
There were a total of 5753 liver transplants during the study period, with 725 performed for
ALF. The median age of patients receiving a liver transplant for ALF was 38 (interquartile
range (IQR) 28 to 49) years, with a greater proportion received by females and Caucasians
(Table 1). When aetiology was classified according to Gotthardt et al [13], 299 (41.2%) patients
presented with ALF secondary to drug-toxicity, a metabolic cause in 40 (5.5%), viral in 36
(5.0%) and vascular in 22 (3.0%), with miscellaneous accounting for 328 (45.3%). Immediately
prior to transplantation, the median value of serum creatinine was 128 μmol/L (IQR 90 to
187), while more than half (389/725) received renal replacement therapy. Within this group,
357 (91.8%) received filtration while 32 (8.2%) received haemodialysis. No patients had signifi-
cant chronic kidney disease prior to acute liver failure. Donors had a median age of 45 (IQR 33
to 56) with the majority of organs from donors with brain death (719 patients, 99.2%).
Patient and graft survival following liver transplantation for ALF
In univariable analyses, the hazard of death for those on RRT was almost twice that of those
not on RRT (Hazard ratio 1.77, 1.28 to 2.44, P<0.001; Table 2). Other factors significantly
associated with reduced patient survival at 3 years were recipient age>40 years old (Hazard
ratio 1.71, 95% CI 1.25 to 2.33, P<0.001), pre-operative serum creatinine120 μmol/L (1.93,
1.40 to 2.68, P<0.001), the use of mechanical ventilation (2.00, 1.37 to 2.94, P<0.001). In those
patients with a pre-operative haemoglobin greater than 10 g/dL, patient death was significantly
reduced (0.72, 0.53 to 0.99, P = 0.042) while gender, acetaminophen-induced ALF and sepsis
had no impact. All other variables (from Table 1) were tested and none found to be associated
with patient survival, including donor age, donor/recipient ethnicity, and cold ischaemic time
(data not shown). Furthermore, the modality of RRT (either filtration or haemodialysis) did
not impact upon either patient or graft survival (data not shown).
The probability of patient survival at 1 and 3 years were 77.7% (95% CI 73.6–81.9) and
74.6% (70.3–79.2) in patients receiving RRT compared with 87.5% (84.0–91.1) and 85.1%
(81.3–89.0) in those not requiring RRT (log-rank test, P = 0.0005; Fig 1A).
Univariable analysis demonstrated predictors of graft failure to be use of RRT (Hazard ratio
1.47, 1.10 to 1.97, P = 0.009), recipient age (1.39, 95% CI 1.05 to 1.84, P = 0.024), pre-operative
serum creatinine concentration (1.76, 1.31 to 2.36, P<0.001), and the use of mechanical venti-
lation (1.71, 1.22 to 2.40, P = 0.002; Table 2). A pre-operative haemoglobin concentration
greater than 10 g/dL was associated with a higher graft survival rate at 3 years post transplanta-
tion (0.88, 0.81 to 0.94, P<0.001).
Graft survival probabilities show a similar pattern: at 1 and 3 years these were 76.1% (95%
CI 72.0 to 80.5) and 72.6% (68.2 to 77.4) in patients receiving RRT compared with 82.6% (78.6
RRT and Survival in Liver Transplantation
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to 86.8) and 79.4% (75.1 to 84.0) in those not requiring RRT (log-rank test, P = 0.0085; Fig 1B).
Primary non-function (13 episodes, 6.9%), chronic rejection (13, 6.9%) or hepatic artery
Table 1. Characteristics of patients, donors and grafts for those receiving liver transplantation for acute liver failure. Values expressed as median
(interquartile range) and number (percent) unless otherwise stated. Missing data for each characteristic is reported, with absolute number in each group
included in parentheses. ALF, acute liver failure; SD, standard deviation; INR, international normalised ratio; RRT, renal replacement therapy; ICH/CVA/Hyp-
oxic, intracranial haemorrhage/cerebral vascular accident/hypoxic brain injury; ICU, intensive care unit; DCD, donation after cardiac death.
No RRT (N = 336) RRT (N = 389) Total (N = 725) Missing data
Recipient characteristics
Age, years 40 (31–51) 36 (27–45) 38 (28–49) 0
Male:Female 1:2.4 1:1.5 1:1.9 0
Ethnicity, Caucasian 265 (78.9) 338 (86.9) 603 (83.2) 0
1st transplant 336 (100.0) 389 (100.0) 725 (100.0) 0
Aetiology of ALF
Viral 22 (6.5) 14 (3.6) 36 (5.0) 0
Drug toxicity 61 (18.2) 238 (61.2) 299 (41.2) 0
Vascular 11 (3.3) 11 (2.8) 22 (3.0) 0
Metabolic 28 (8.3) 12 (3.1) 40 (5.5) 0
Miscellaneous 214 (63.7) 114 (29.3) 328 (45.3) 0
Characteristics immediately prior to transplant
Encephalopathy, mean grade (SD) 3.6 (1.5) 4.5 (1.4) 4.1 (1.2) 3 (1/2)
Sepsis 21 (6.2) 35 (9.0) 56 (7.7) 7 (4/3)
Mechanical ventilation 142 (42.3) 353 (90.8) 495 (68.3) 0
Intracranial pressure measurement
Normal 16 (4.8) 50 (12.9) 69 (7.5) 0
Raised 16 (4.8) 117 (30.1) 136 (14.7) 0
Not used 304 (90.5) 222 (57.1) 526 (72.6) 0
Bilirubin, μmol/L 337 (184–462) 147 (86–296) 235 (106–404) 1 (0/1)
Albumin, g/L 25 (21–28) 24 (20–28) 24. (21–28) 3 (2/1)
Sodium, mmol/L 139 (134–144) 141 (136–146) 140 (135–145) 0
Creatinine, μmol/L 99 (75–135) 157 (117–237) 128 (90–187) 0
Urea, μmol/L 4.1 (2.3–7.3) 5.5 (3.3–8.7) 4.9 (2.7–8.2) 9 (2/7)
INR 2.7 (2.0–4.3) 3.1 (2.1–5.3) 2.9 (2.1–4.8) 49 (13/36)
Haemoglobin, g/dL 10.6 (9.0–12.4) 9.0 (8.1–10.3) 9.6 (8.4–11.5) 0
Platelets, 109/L 110 (74–168) 70 (47–102) 86 (56–134) 0
pH 7.45 (7.40–7.47) 7.35 (7.23–7.43) 7.40 (7.30–7.46) 582 (280/302)
Donor/graft characteristics
Age, years 45 (33–55) 45 (33–56) 45 (33–56) 0
Weight, kg 70 (62–80) 70 (65–80) 70 (65–80) 1 (1/0)
Height, cm 168 (160–177) 170 (163–178) 170 (162–178) 10 (5/5)
Cause of death
ICH/CVA/Hypoxic 261 (77.7) 283 (72.7) 544 (75.0) 0
Trauma 47 (14.0) 68 (17.5) 115 (15.9) 0
Other 28 (8.3) 38 (9.8) 66 (9.1) 0
ICU days 1.7 (1.3–3.3) 1.8 (1.3–2.9) 1.8 (1.3–3.1) 51 (25/26)
Ethnicity, Caucasian 326 (97.0) 376 (96.7) 702 (96.8) 3 (3/0)
Steatosis 108 (32.1) 138 (35.5) 246 (33.9) 20 (13/7)
DCD proportion 0 6 (1.5) 6 (0.8) 0
Cold ischemic time, min 567 (474–671) 537 (437–640) 549 (451–654) 26 (6/20)
doi:10.1371/journal.pone.0148782.t001
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thrombosis (13, 6.9%, S4 Table) were the predominant causes of graft failure in the cohort.
Graft failure was the cause of patient death in 3 cases.
A total of 161 (22.2%) patients in the cohort died. Causes of death included multi-organ fail-
ure (54 cases, 33.5%), septicaemia (22, 13.7%), cardiac causes (5, 3.1%), major haemorrhage (5,
3.1%) and cerebrovascular accidents (5, 3.1%).
Relationship between serum creatinine, RRT and survival
Elevated pre-operative serum creatinine was found to be significantly associated with a reduc-
tion in both patient and graft survival in univariable analyses (Fig 1C and 1D). At 1 year,
patient and graft survival were 87.8% (95% CI 84.4–91.4) and 84.0% (95% CI 80.1–88.0) in
patients with a baseline creatinine of<120 μmol/L. Patients with a higher creatinine concen-
tration (120 μmol/L) had a significantly worse outcome for both patient (77.3% (95% CI
73.2–81.6; log-rank test, P<0.0001)) and graft survival (74.9% (95% CI 70.7–79.4; log-rank
test, P = 0.0002)).
In multivariable Cox proportional hazards (CPH) models, use of RRT was associated with
patient death (hazard ratio (HR) 1.59, 95% CI 1.01 to 2.50, p = 0.044; Table 3) when creatinine
was centred at a value of 90 μmol/L. Other variables associated with patient death were recipi-
ent age ((per 10 years) 1.32, 1.17 to 1.49, P<0.001) and the use of ventilatory support (1.69,
1.09 to 2.63, P = 0.020). A pre-operative haemoglobin greater than 10 g/dL was associated with
a reduced hazard of patient death (0.90, 0.83 to 0.98, P = 0.018). However, RRT was not a pre-
dictor of graft loss (1.39, 0.92 to 2.10, P = 0.114), while pre-operative haemoglobin greater than
10g/dL was independently associated with graft loss (0.92, 0.85 to 0.99, P = 0.025). A total of 9
patients were excluded from the multivariate analysis due to missing values.
The influence of serum creatinine concentration on outcome was examined accounting for
an expected interaction with RRT, that is, the strength of association of serum creatinine with a
given outcome might be expected to be different for those on RRT compared with those not on
RRT. Serum creatinine was seen to be an independent predictor of both patient death (HR (per
10 units) 1.04, 1.01 to 1.07, P = 0.008) and graft loss (1.05, 95% CI 1.02 to 1.07, P = 0.001) even
after accounting for the interaction with RRT.
The relationship between pre-operative creatinine, use of RRT and outcome was explored
with modelling (Fig 2). Patients with a pre-operative serum creatinine120 μmol/L in the
absence of RRT had a similar probability of both patient death and graft failure as those receiv-
ing RRT (Fig 2A and 2B). Using a two-dimensional heat-map, the relationship between age,
Table 2. Univariable analysis of risk factors for patient death and graft loss after liver transplantation for acute liver failure. Hazard ratios were
determined using Cox Proportional Hazards model. Values in parentheses are 95% confidence intervals.
Patient death Graft loss
Hazard ratio P-value Hazard ratio P-value
Recipient age (40) 1.71(1.25–2.33) <0.001 1.39 (1.05–1.84) 0.024
Gender (female) 1.00 (0.73–1.39) 0.984 1.03 (0.77–1.39) 0.833
Acetaminophen-induced ALF 1.20 (0.87–1.66) 0.267 0.84 (0.62–1.13) 0.246
Haemoglobin (10 g/dL) 0.72 (0.53–0.99) 0.042 0.88 (0.81–0.94) <0.001
Creatinine (120 μmol/L) 1.93 (1.40–2.68) <0.001 1.76 (1.31–2.36) <0.001
RRT 1.77 (1.28–2.44) <0.001 1.47 (1.10–1.97) 0.009
Ventilatory support 2.00 (1.37–2.94) <0.001 1.71 (1.22–2.40) 0.002
Sepsis 1.46 (0.87–2.44) 0.153 1.49 (0.93–2.40) 0.097
doi:10.1371/journal.pone.0148782.t002
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serum creatinine, use of RRT and survival is demonstrated (Fig 2C and 2D). These plots show
that those with an elevated creatinine but not on RRT have a numerically higher probability of
both death and graft failure than those on RRT.
Fig 1. The effect of renal replacement therapy and serum creatinine on survival. Kaplan-Meier plots demonstrating the effect of both renal replacement
therapy (A&B) and pre-operative serum creatinine (C&D) on patient and graft survival respectively in liver transplantation for acute liver failure. P value
calculated using log-rank test.
doi:10.1371/journal.pone.0148782.g001
RRT and Survival in Liver Transplantation
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Propensity-score based matched analysis
The interaction between pre-operative serum creatinine and the requirement for RRT on sur-
vival was analysed using a matched dataset and CPH model. Propensity-score based matching
achieved excellent covariate balance (S3 Table) across the full range of the propensity score (S2
Fig). For those receiving RRT, risk of patient death at one year remained similar regardless of
serum creatinine concentration (Fig 3A). However, an inverse relationship was seen between
serum creatinine and graft survival in those not receiving RRT, while in the presence of RRT
risk of graft failure remained similar (Fig 3B and S5 Table). Propensity-score based matching
demonstrated that at a serum creatinine greater than 175 μmol/L, patients not receiving RRT
had a significantly worse risk of graft failure than all those receiving RRT (Fig 3C). In total 56
patients (21.1%) had a serum creatinine greater than 175 μmol/L but did not receive RRT. In
the unmatched dataset the result was similar, with a serum creatinine greater than 200 μmol/L
in those not receiving RRT demonstrating a worse risk of graft failure (S3 Fig).
Discussion
This is the first study to our knowledge to concurrently investigate the influence of renal
replacement therapy (RRT) and pre-operative serum creatinine on survival following liver
transplantation for acute liver failure. This retrospective analysis of a national population data-
base demonstrated that RRT and serum creatinine were both independent predictors of patient
survival, while creatinine was also a predictor of graft loss. For those not on RRT, outcome gets
worse as creatinine rises. Even in patients with only a moderately elevated creatinine, outcomes
were equivalently poor to those receiving RRT. When accounting for potential confounding
factors, elevated serum creatinine predicted an increased risk of graft failure for those not
receiving RRT, however this effect was lost in the presence of RRT.
Half of the cohort in this study required RRT prior to transplantation for acute liver failure,
which is consistent with published literature [6]. Elevated serum creatinine and use of RRT are
likely to represent an acute deterioration in renal function in this cohort and previous studies
demonstrate a clear association between ALF and acute kidney injury [5]. Renal dysfunction is
known to independently predict patient and graft survival in liver transplantation for any indi-
cation [3, 11], with the increased sepsis rate associated with renal dysfunction hypothesised as
a possible explanation [7–9]. In acute liver injury, our results suggest that renal dysfunction is a
measure of progressive organ system failure. This is supported by our observation of the
Table 3. Multivariable analysis of pre-operative risk factors for patient death and graft loss in those undergoing liver transplantation for acute liver
failure. Cox Proportional Hazards model using variables found to be significant in univariable analysis (P<0.05) and those thought to be clinically significant.
Serum creatinine was centred at a value of 90 μmol/L for the purposes of the analysis. Patient survival data was only considered for patients receiving their
first liver transplantation. Values in parentheses are 95% confidence intervals.
Patient death Graft loss
Hazard Ratio P-value Hazard Ratio P-value
Recipient age (/10 years) 1.32 (1.17–1.49) <0.001 1.17 (1.04–1.31) 0.007
Haemoglobin 0.90 (0.83–0.98) 0.018 0.92 (0.85–0.99) 0.025
Creatinine (/10 μmol/L) 1.04 (1.01–1.07) 0.008 1.05 (1.02–1.07) 0.001
RRT 1.59 (1.01–2.50) 0.044 1.39 (0.92–2.10) 0.114
Ventilatory support 1.69 (1.09–2.63) 0.020 1.47 (0.92–2.10) 0.057
Sepsis 1.17 (0.69–1.98) 0.558 1.30 (0.80–2.10) 0.290
Creatinine:RRT interaction 0.96 (0.93–0.99) 0.038 0.96 (0.93–0.99) 0.009
doi:10.1371/journal.pone.0148782.t003
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additive negative effect of mechanical ventilation on patient survival and that renal dysfunction
is known to prolong intensive care unit stay [4, 7].
In acute liver failure, a requirement for RRT may be a surrogate for metabolic dysfunction
or systemic complications. Factors such as disseminated intravascular coagulation, hypovolae-
mia and sepsis all increase the likelihood of renal dysfunction [19, 20]. Our methods attempted
to control for such confounding, with RRT associated with worse survival, independent of bio-
chemical/coagulation disturbance and the requirement for mechanical ventilation, variables
likely to reflect critically unwell patients. RRT is associated with poor outcomes in liver trans-
plantation for indications other than acute liver failure [21]. It has been suggested that RRT in
liver transplant recipients increases the risk of both bacterial and fungal sepsis [22, 23]. We
Fig 2. The interaction between renal replacement therapy and elevated creatinine on patient and graft survival. Kaplan-Meier plots demonstrating the
interaction between pre-operative creatinine concentration and requirement for RRT on patient (A) and graft survival (B); P value calculated using log-rank
test. Probability of death at one year following liver transplant by pre-operative serum creatinine level, RRT and recipient age is shown for patient (C) and
graft survival (D). Models use Cox proportional hazards, with co-variable patient characteristics adjusted to haemoglobin concentration of 10 g/dL,
requirement of mechanical ventilation and absence of sepsis.
doi:10.1371/journal.pone.0148782.g002
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found a greater proportion of deaths in patients with RRT attributed to sepsis (15 vs. 7), how-
ever the numbers here are too small to draw firm conclusions.
RRT has the ability to correct electrolyte imbalance, acid-base disturbance and limit coagu-
lopathy [24, 25]. The function of RRT to correct physiological parameters could explain the
effect of RRT on graft survival in a propensity-score matched data set. For example, it is well
described that lactic acidosis is associated with increased hepatocellular damage and necrosis
in the immediate period following liver transplantation [26, 27]. Correction of metabolic acido-
sis through the use of RRT may reduce hepatocellular damage and as a consequence minimise
risk of graft dysfunction.
In contrast we did not demonstrate the presence of pre-operative RRT significantly reduced
patient mortality following liver transplantation for ALF. This finding has been replicated pre-
viously in observational studies [28]. Other pre- and post-operative factors are likely to con-
tribute to patient survival, with evidence suggesting response to various therapeutic strategies
at day 7 post-transplantation (such as oxygen saturation, hypotension and level of inotropic
support) predict survival [29, 30]. This suggests delayed recovery from multi-organ dysfunc-
tion following transplantation is an important marker for survival and therefore the cumulative
effect of multi-organ dysfunction is likely to predict patient survival. As a result, the presence
of RRT may have an additive effect on patient mortality in the presence of other organ support
systems but may explain why it does not independently predict patient mortality. However,
evidence suggests that the same patient cohort also has a higher rate of acute rejection and
hence graft failure [28]. RRT may therefore provide an important, currently unidentified, indi-
vidual mechanism in reducing graft failure compared to other organ support systems (as dis-
cussed previously) that would explain the effect of RRT in improving graft survival in this
study.
Clinical studies suggest that increased doses of haemofiltration are associated with a reduced
mortality in patients with sepsis [31, 32], possibly explained by increased removal of sepsis
mediators from the circulation [33]. However controlled trials have demonstrated higher
intensity RRT has no benefit, either on survival or renal recovery, in patients with acute kidney
injury secondary to sepsis [34, 35]. Furthermore, a multi-centre randomized trial suggested
early application of venovenous hemofiltration in a similar cohort of patients was deleterious
Fig 3. Renal replacement therapy and survival in a matched dataset. Probability of patient (A) and graft survival (B) at one year following liver transplant
by pre-operative serum creatinine level and RRT requirement in a matched dataset. In patients not receiving RRT, a pre-operative serum creatinine of
greater than 175 μmol/L had a significantly greater risk of graft failure compared to those receiving RRT (C; black line indicates hazard ratio = 1, shaded
areas represent 95% CI). Cox proportional hazards model with groups fully matched for baseline covariates used for each analysis.
doi:10.1371/journal.pone.0148782.g003
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to organ function [36]. Studies investigating intensity and timing of RRT in patients requiring
transplantation for ALF are yet to be performed. Further work requires to be done on identify-
ing the optimum timing for commencement of RRT, but commencing RRT early or using a
low threshold for its institution may turn out to be beneficial.
Currently, our study demonstrates the potential of RRT in improving graft survival if com-
menced when a patient’s pre-operative creatinine rises above 175 μmol/L. The authors suggest
that further prospective evidence is required before firm conclusions can be made regarding its
implication in clinical practice, however the commencement of RRT should be considered in
those patients where creatinine rises above 200 μmol/L. In addition, a creatinine of
<200 μmol/L would not necessarily be contraindicated if it is required for other purposes such
as refractory pulmonary oedema or hyperkalaemia.
The retrospective and observational nature of this study has limitations. Unfortunately data
were not available for patient baseline renal function prior to development of acute liver failure,
and despite attempting to account for confounding factors with propensity-score matching, an
element of confounding may remain in the form of RRT indication, timing and modality,
which is known to be diverse in clinical practice [35]. Furthermore pre- and post-operative
Sequential Organ Failure Assessment (SOFA) and Model for End-Stage Liver Disease (MELD)
scores, known to accurately predict short-term prognosis in liver transplantation [28], are not
available within the dataset. This may limit the generalization of our findings. Further investi-
gation of RRT in patients with ALF would be useful, particularly whether early initiation of
RRT has a beneficial effect.
This study has important implications in relation to the management patients with renal
impairment prior to transplantation. We have demonstrated that RRT is a predictor of patient
death, while serum creatinine concentration independently predicts graft failure in the absence
of RRT. By demonstrating graft survival is equivalent in those patients receiving RRT regard-
less of serum creatinine concentration, further studies need to identify whether timing and
indication of pre-operative RRT improves long-term graft survival in those undergoing liver
transplantation for acute liver failure.
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